Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Expansion of Clinical Development of RVU120 in Low-Risk Myelodysplastic Syndromes (LR-MDS)
Saturday, October 21, 2023Ryvu Therapeutics a clinicalstage drug discovery and development company focusing on novel small molecule therapies addressing emerging targets in oncology announced today that it entered into a Clinical Trial Financial Support agreement
Biontech Expands Late-stage Clinical Oncology Portfolio With Initiation of Further Phase 2 Trial With MRNA-based Individualized Neoantigen Specific Immunotherapy in New Cancer Indication
Friday, October 20, 2023BioNTech SE today announced that the first patient has been treated in a Phase clinical trial evaluating the mRNAbased individualized neoantigenspecific immunotherapy candidate autogene cevumeran
Spago Nanomedical Receives Approval to Initiate the Clinical Phase I/IIa Study With Tumorad® in Australia
Friday, October 20, 2023Spago Nanomedical AB announces today that the companys application to start the clinical phase IIIa study Tumorad with the candidate drug LuSN in cancer patients
Umoja Biopharma Announces Opening of Development and Manufacturing Facility in Louisville, Colorado
Friday, October 20, 2023Umoja Biopharma Inc a transformative immunooncology company creating offtheshelf treatments for solid and hematologic cancers announced today the opening of its new development and manufacturing facility
AN2 Therapeutics Signs License Agreement with the University of Georgia Research Foundation to Develop Novel Boron-Based Therapy for Chagas Disease
Thursday, October 19, 2023AN Therapeutics Inc a clinicalstage biopharmaceutical company focused on developing treatments for rare chronic and serious infectious diseases with high unmet needs today announced that it has received an exclusive license
Hookipa Pharma Announces Publication of Preclinical Data of Hepatitis B Virus (HBV) Therapeutic Vaccine Developed in Collaboration With Gilead Sciences
Thursday, October 19, 2023HOOKIPA Pharma Inc a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform today announced that The Journal of Infectious Diseases has published preclinical data on HB
European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage III Hodgkin Lymphoma in Combination with AVD
Thursday, October 19, 2023Takeda today announced that the European Commission approved ADCETRIS in combination with doxorubicin vinblastine and dacarbazine to treat adult patients with previously untreated CD Stage
CytoAgents Announces Initiation of Patient Enrollment in Phase 1b/2a Clinical Trial to Treat Cytokine Release Syndrome in CAR T-cell Therapy
Wednesday, October 18, 2023CytoAgents Inc a clinicalstage biotechnology company developing a safe effective treatment for Cytokine Release Syndrome today announced that it has initiated recruitment and will enroll its first patient at UPMC Hillman Cancer Center
Lisata Therapeutics Announces European Medicines Agency Has Granted LSTA1 Orphan Drug Designation for the Treatment of Pancreatic Cancer
Wednesday, October 18, 2023Lisata Therapeutics Inc a clinicalstage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases today announced that the European Medicines Agency
Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility
Wednesday, October 18, 2023Avid Bioservices Inc a dedicated biologics contract development and manufacturing organization CDMO working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies
